Chronic Kidney Disease (CKD) Market Analysis: Global Industry Size, Growth and Forecast
Report ID : 1303377 | Published : June 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Chronic Kidney Disease (CKD) Market is categorized based on Treatment Type (Dialysis, Kidney Transplant, Medication, Lifestyle Changes) and End-User (Hospitals, Dialysis Centers, Home Care, Pharmacies) and Stage of Disease (Early Stage, Chronic Stage, End-Stage) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
Valued at 80 billion USD in 2023, the Chronic Kidney Disease (CKD) Market size is expected to grow to 130 billion USD by 2033, with a CAGR of 5.1% from 2024 to 2033. The report comprises various segments and analyzes the trends and factors playing a substantial role in the market.
Chronic Kidney Disease (CKD) is one of the most serious global health concerns due to its high human impact in terms of loss of functioning and requirements to the health systems across the globe. But the situation is even worse; chronic kidney diseases (CKD) are often in their early stages because of its insidious nature which eventually results in major complications and a significant reduction of quality of life of the patients. It is for such reasons why the CKD treatment and management market has expanded; the number of elderly individuals are rising in addition to new risk factors like diabetes, and hypertension becoming commonplace. This evolving landscape poses possibilities for healthcare providers, pharmaceutical companies, and medical equipment manufacturers to upgrade and repair existing treatment modalities.
The CKD market consists of several categories of goods and services, such as pharmaceuticals, diagnostic, and renal replacement therapies. The need for advancement to the reno replacement therapy market is dramatic due to the ever-growing demand for better technological interventions. The growing concern about CKD and its associated factors has also shifted the market into a more proactive approach with respect to early intervention. By utilizing these integrated comprehensive market research, stakeholders can make the best out of this intricate scenario, identify prospective areas of growth, and aid in the improvement of patient outcomes towards chronic kidney disease.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Fresenius Medical Care, DaVita Inc., Baxter International Inc., Abbott Laboratories, Amgen Inc., Johnson & Johnson, Novartis AG, Roche Holding AG, Eli Lilly and Company, Merck & Co. Inc., AstraZeneca PLC |
| SEGMENTS COVERED |
By Treatment Type - Dialysis, Kidney Transplant, Medication, Lifestyle Changes
By End-User - Hospitals, Dialysis Centers, Home Care, Pharmacies
By Stage of Disease - Early Stage, Chronic Stage, End-Stage
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Chronic Kidney Disease (CKD) Market Dynamics
The Chronic Kidney Disease (CKD) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Chronic Kidney Disease (CKD) Market Segmentations
Market Breakup by Treatment Type
- Overview
- Dialysis
- Kidney Transplant
- Medication
- Lifestyle Changes
Market Breakup by End-User
- Overview
- Hospitals
- Dialysis Centers
- Home Care
- Pharmacies
Market Breakup by Stage of Disease
- Overview
- Early Stage
- Chronic Stage
- End-Stage
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Chronic Kidney Disease (CKD) Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Fresenius Medical Care
- DaVita Inc.
- Baxter International Inc.
- Abbott Laboratories
- Amgen Inc.
- Johnson & Johnson
- Novartis AG
- Roche Holding AG
- Eli Lilly and Company
- Merck & Co. Inc.
- AstraZeneca PLC
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved